We are live on
!
Find out more
ACM
Aster Capital Management Portfolio holdings
AUM
$470M
1-Year Est. Return
25.86%
This Fund
S&P 500
This Quarter
Est. Return
+15.58%
1 Year Est. Return
+25.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$470M
AUM Growth
+$164M
(+54%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
27.73%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,328
New
519
Increased
184
Reduced
104
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$8.94M |
| 2 |
Apple
AAPL
|
+$7.66M |
| 3 |
Honeywell
HON
|
+$6.23M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$5.6M |
| 5 |
Microsoft
MSFT
|
+$5.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$15.2M |
| 2 |
VanEck Oil Services ETF
OIH
|
+$9.62M |
| 3 |
State Street SPDR S&P Homebuilders ETF
XHB
|
+$9M |
| 4 |
State Street SPDR S&P Insurance ETF
KIE
|
+$7.87M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$7.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Industrials | 16.51% |
| 3 | Miscellaneous | 11.79% |
| 4 | Financials | 11.28% |
| 5 | Healthcare | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Merchants Bancorp
MBIN
$2.36B
| $7.2K | ﹤0.01% |
+144
| New | +$6.84K |
|
702
Robert Half
RHI
$3.77B
| $7.09K | ﹤0.01% |
231
-320
| -58% | -$8.96K |
|
703
Amylyx Pharmaceuticals
AMLX
$4.24B
| $7.06K | ﹤0.01% |
+393
| New | +$6.08K |
|
704
Savers
SVV
$1.4B
| $6.71K | ﹤0.01% |
665
-396
| -37% | -$3.43K |
|
|
PPLI
705
People Inc
PPLI
$2.72B
| $6.65K | ﹤0.01% |
144
-29,321
| -100% | -$1.25M |
|
|
MAZE
706
Maze Therapeutics
MAZE
$1.24B
| $6.59K | ﹤0.01% |
+221
| New | +$5.79K |
|
707
Global Industrial
GIC
$1.51B
| $6.59K | ﹤0.01% |
197
-51
| -21% | -$1.62K |
|
|
PSTL
708
Postal Realty Trust
PSTL
$727M
| $6.36K | ﹤0.01% |
+258
| New | +$5.76K |
|
709
Tronox
TROX
$663M
| $6.12K | ﹤0.01% |
+972
| New | +$8.24K |
|
710
Global Net Lease
GNL
$2.04B
| $5.98K | ﹤0.01% |
+669
| New | +$6.26K |
|
|
ATAI
711
DELISTED
AtaiBeckley Inc
ATAI
| $5.91K | ﹤0.01% |
+1,122
| New | +$4.72K |
|
712
DexCom
DXCM
$33.6B
| $5.86K | ﹤0.01% |
87
-1,208
| -93% | -$80.5K |
|
713
Liberty Latin America Class C
LILAK
$1.65B
| $5.73K | ﹤0.01% |
+736
| New | +$5.33K |
|
714
SiteOne Landscape Supply
SITE
$3.9B
| $5.61K | ﹤0.01% |
+49
| New | +$5.92K |
|
715
Phathom Pharmaceuticals
PHAT
$611M
| $5.51K | ﹤0.01% |
+508
| New | +$5.8K |
|
716
Birkenstock
BIRK
$5.11B
| $5.42K | ﹤0.01% |
126
-5,111
| -98% | -$207K |
|
717
Stepan Co
SCL
$1.39B
| $5.35K | ﹤0.01% |
+96
| New | +$4.99K |
|
|
MCHB
718
Mechanics Bancorp
MCHB
$3.39B
| $5.33K | ﹤0.01% |
+335
| New | +$5.02K |
|
719
Enovis
ENOV
$1.02B
| $5.3K | ﹤0.01% |
256
-566
| -69% | -$13.3K |
|
720
Recursion Pharmaceuticals
RXRX
$1.97B
| $5.21K | ﹤0.01% |
1,419
+809
| +133% | +$2.69K |
|
721
Pacira BioSciences
PCRX
$981M
| $5.13K | ﹤0.01% |
202
-114
| -36% | -$2.69K |
|
722
CRA International
CRAI
$1.03B
| $4.98K | ﹤0.01% |
+35
| New | +$5.26K |
|
723
Biohaven
BHVN
$2.1B
| $4.97K | ﹤0.01% |
+334
| New | +$3.6K |
|
724
Ingles Markets
IMKTA
$1.56B
| $4.96K | ﹤0.01% |
+56
| New | +$5.01K |
|
725
Collegium Pharmaceutical
COLL
$721M
| $4.85K | ﹤0.01% |
+134
| New | +$4.58K |
|
Similar funds
BFA
JHC
AIM
HNWAG
BTWM
DBRC
WPIC
DWML
Aster Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Aster Capital Management held 1,328 positions worth $470M, up 54% from $306M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Aster Capital Management deployed $130M of net new capital in Q2 2026, opening 519 new positions and adding to 184 existing holdings. Its largest new stake was Apple: 26,770 shares worth $7.75M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 8.4% a quarter earlier, followed by Industrials and Miscellaneous.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $15.2M trimmed.
- Aster Capital Management's largest Q2 2026 buy was Apple: 26,770 shares worth $7.75M.
- Aster Capital Management added most to iShares US Real Estate ETF in Q2 2026, an estimated $8.94M increase.
- Aster Capital Management's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $15.2M.
- Aster Capital Management fully exited State Street SPDR S&P Homebuilders ETF in Q2 2026, selling an estimated $9M.
- Aster Capital Management's ten largest holdings make up 13% of its $470M portfolio in Q2 2026.
- Aster Capital Management opened 519 new positions and closed 520 in Q2 2026.
- Aster Capital Management's portfolio value rose 54% quarter-over-quarter to $470M.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.